Oleclumab (MEDI9447) is a human IgG1lambda monoclonal antibody targeting CD73 and inhibits the exonuclease activity of the extracellular enzyme CD73. Oleclumab can adjust the composition of bone marrow and lymphoid infiltrating leukocyte populations in the tumor microenvironment and has anti-tumor activity[1][2].
Molecular Weight:
(143.14 kDa)
Purity:
99.90
CAS Number:
[1803176-05-7]
Target:
CD73
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted